chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm hurts a lot; Injection site is a little warm; Making her sweat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts a lot), VACCINATION SITE WARMTH (Injection site is a little warm) and HYPERHIDROSIS (Making her sweat) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.  On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurts a lot), VACCINATION SITE WARMTH (Injection site is a little warm) and HYPERHIDROSIS (Making her sweat). At the time of the report, PAIN IN EXTREMITY (Arm hurts a lot), VACCINATION SITE WARMTH (Injection site is a little warm) and HYPERHIDROSIS (Making her sweat) had not resolved.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
chronic urticaria week after shot; hives are a small itch in one spot/The hives popped up; hives are a small itch in one spot/The hives popped up; develops angry red rash, with hives; This spontaneous case was reported by an other health care professional and describes the occurrence of URTICARIA CHRONIC (chronic urticaria week after shot), URTICARIA (hives are a small itch in one spot/The hives popped up), PRURITUS (hives are a small itch in one spot/The hives popped up) and RASH ERYTHEMATOUS (develops angry red rash, with hives) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     Concurrent medical conditions included Cold sores. Concomitant products included VALACYCLOVIR [VALACICLOVIR] for Cold sores, SERTRALINE and ATORVASTATIN for an unknown indication.    On 30-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced URTICARIA CHRONIC (chronic urticaria week after shot), URTICARIA (hives are a small itch in one spot/The hives popped up), PRURITUS (hives are a small itch in one spot/The hives popped up) and RASH ERYTHEMATOUS (develops angry red rash, with hives). The patient was treated with METHYLPREDNISOLONE SODIUM SUCCINATE (SOLUMEDROL) for Hives, at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Hives, at a dose of 2 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Hives, at a dose of 50 mg. At the time of the report, URTICARIA CHRONIC (chronic urticaria week after shot), URTICARIA (hives are a small itch in one spot/The hives popped up) and PRURITUS (hives are a small itch in one spot/The hives popped up) had not resolved and RASH ERYTHEMATOUS (develops angry red rash, with hives) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter called on behalf of her husband who developed chronic urticaria a week after receiving his Moderna COVID-19 booster dose.  The hives popped up, he went to a local urgent care, they gave him a steroid pack for 5 days. The patient took Zyrtec in the morning and Benadryl at night.  The angry red rash, with hives were transient and then goes away. patient had a follow up appointment.   This case was linked to MOD-2021-403273, MOD-2021-403274, MOD-2021-402691 (Patient Link).
Had headache, muscle and back pain, dizziness, it lasts only one day only.  After that headache. On September 20 she went to the hospital because she had diarrhea, vomiting, fever and dehydration.  The hospital gave her medicine for vomiting only. Hair is also falling from head.
FULL BODY ACHES; CHILLS; ARM PAIN; LOW-GRADE FEVER; FATIGUE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21a,expiry: not reported) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced full body aches. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced arm pain. On APR-2021, the subject experienced low-grade fever. On APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from full body aches, chills, low-grade fever, and fatigue on APR-2021, and had not recovered from arm pain. This report was non-serious.
Patient requested pfizer booster may have been given Fluad instead. This would the patient's second fluad in the season
Fever, Chills, Body Aches, Joint Pain, Malaise lasting approx 6 hours.
fever, chills, body ache, headache, joint ache for 36 hours, followed by general malaise and headache for 2 days 6 days later started with a poison ivy-like rash over my entire body and visited the dermatologist the following day  the rash lasted 10 days with some flare-ups for another week Dr. prescribed topical creams to treat the itching
Began having upset stomach, headache, body ache, fever the day after the shot was received and continued until Monday when she was found unresponsive.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2016-2017 season) for prophylaxis. Previously administered products included Flu vaccine with an associated reaction of injection site pain (patient had gotten the flu vaccine every year for the past nine years). On an unknown date, the patient received Influenza vaccine Quadrivalent 2016-2017 season (intramuscular). On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent 2016-2017 season, the patient experienced injection site pain. Rechallenge with Influenza vaccine Quadrivalent 2016-2017 season was positive. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to Influenza vaccine Quadrivalent 2016-2017 season. Additional details were provided as follows: The age at the vaccination was not reported. The patient reported that she has gotten the flu vaccine every year for the past nine years and it usually hurts a little at the injection site, but resolved after a couple days. This was second of the 9 cases reported by the same reporter for the same patient.
After an hour I had the vaccine I started having fast heart palpitations and my chest started to compress. My blood pressure was 176/148 and I had to go to the ER.
This spontaneous report as received from a pharmacist refers to a 64 year old female patient with no pertinent medical history or drug allergies. On 15-MAR-2013 the patient was vaccinated with ZOSTAVAX (lot # H019035; expiry date: 17-JAN-2014), 0.65 ml, subcutaneous. Concomitant therapies included ELMIRON 100 mg (2 tablets twice a day). On 16-MAR-2013, the patient experienced a red place on the arm at the injection site that was a circle and wider area around the circle that was not quite as red, area was warm/hot to the touch, "tough and swollen", pain that came down the arm, itchy, and sores on the corners of the mouth. The pain had gone away and the redness had gotten a little better. The outcome of the red place on the arm at the injection site, area was warm/hot to the touch, "tough and swollen", itchy and sores on the corners of the mouth was reported as recovering. The patient was advised to take BENADRYL. Patient had sought medical attention via calling physician and visiting pharmacy. No lab tests were performed. Pharmacist was requesting a lot check. This is one of the reports from the same reporter. Additional information has been requested.
In 03/22/2021 Nausea started around 4, by 7 pm I felt back pain and head aches, by 8 pm I had a 100.2 fever. Fever all night, but I didn?t feel cold instead I felt I was burning I felt so hot checked temperate and it was 102 degrees, I could not get up from the bed my body hurt and it felt heavy. I was not able to go to work. Today 03/23/2021 the fever was between 99.9 to 100, back pain and head ache, and I feel weak tired. I didn?t take anything for pain because I read it could have adverse effects on the vaccine.
Approximately 16 hours after receiving the vaccine, had pounding headache; Chills; Nausea; Body aches; Dizzy; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via an unspecified route of administration in the left arm on 06Apr2021 at 09:00 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. The patient received unspecified medications within 2 weeks of vaccination. The patient previously received infliximab (REMICADE) and levofloxacin (LEVAQUIN) on unknown dates for unspecified indications and experienced drug allergy Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 01:00, approximately 16 hours after receiving the vaccine, the patient experienced pounding headache, chills, nausea, body aches, dizzy and brain fog. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events approximately 16 hours after receiving the vaccine, had pounding headache, chills, nausea, body aches, dizzy and brain fog were resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Narrative: Patient was seen at outside ED and discharged for reported ADR to COVID vaccine after receiving the first dose of the vaccination. No records are available to know what treatment/diagnosis was made at the ED at the time of  visit. Patient self-reported the incident to the RN.
Patient felt ringing in ears, darken vision, and feeling faint seconds after injection. After drinking water and breathing deeply, patient's symptoms resolved in about 5 minutes.
red rash on lower left leg.   after 3 days it disappeared.  day 5 it has reappeared,
Patient was administered the vaccine at approximately 10:25 am and advised that he should remain in the store for 15 minutes to monitor for possible adverse reactions. At approximately 10:30 am the patient walked out the front door of the store and immediately fell face first on the side walk. I was contacted and did an assessment. His blood pressure was 110/50 with a pulse of 50. He was fully oriented and stated he continued to feel light headed. An ambulance was called and the patient was taken to the hospital for evaluation.
Immediately felt light headed, soon after felt dizzy; Bad nausea; Stomach felt uneasy; This is a spontaneous report received from a contactable other healthcare professional, the patient. A non-pregnant female patient of unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the right arm on 09Mar2021 at 14:00 as single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food and other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Concomitant medication included flu vaccine (MANUFACTURER UNKNOWN) on 24Feb2021. The patient did not receive any other vaccines within 2 weeks prior to the COVID-19 vaccine. On 09Mar2021 at 14:00, the patient experienced light headed, nausea and stomach discomfort. The patient did not receive any treatment for the reported events. The clinical outcome of events light headed, nausea and stomach discomfort were recovered on an unknown date in Mar2021.   No follow-up attempts are possible. No further information is expected.
On 11MAR2023 I went to a community theatre play with no mask on 14MAR2023 I woke feeling like I was getting  sick a lot of nasal drainage. 15MSAR2023 I took a home Covid test I went to the clinic  @ 4PM but tit was to late to see a Doctor a Tele visit was arranged for 16MAR2023. On 16MAR2023 I spoke with PAC telemedicine by phone, she prescribed Paxlovid which I started taking the same day I got better for a while then on 25MAR2023 I was really sick and went to the ER at Hospital they told me my lungs were clear so I should just stay home and take Tylenol. I was sick for =three weeks. the ER Doctor said the Paxlovid did its job as it stopped the infection from attacking  my body systems.
Random rose bleeds, vertigo, and shortness of breath. No treatment, recurring issues of the above reactions.
has been exposed to the virus multiple times; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administration date 17Mar2021 (Lot number: EN6206) as dose 1, single and administration date 07Apr2021 (Lot number: ER8729) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications.  The following information was reported: EXPOSURE TO SARS-COV-2 (non-serious) with onset 2021, outcome "unknown", described as "has been exposed to the virus multiple times". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: It was stated that the caller worked in the airport. The caller didn't have any symptoms with the first 2 doses of the vaccine and had been exposed to the virus multiple times but never had the virus. The caller's daughter had the virus last year for Christmas and the caller took care of her daughter and monitored her temperature and oxygen level. The caller's daughter had a bad reaction to the virus and the caller never got the virus while she was taking care of her.The caller notes that she had the rapid covid test on 21Nov2021 at the clinic in the airport which was negative. The caller seen her doctor on 17Nov2021and they did her blood work and checked her covid antibodies. The caller's antibodies were positive this time but they were negative in the past. The caller is unsure when her antibodies were checked previously, she is unsure if she had her covid vaccines yet at this point. The caller will have to ask her doctor about this. First Dose: NDC, and expiration date unknown.Second Dose: NDC, and expiration date unknown.  No follow-up attempts are possible. No further information is expected.
Itchy arms, redness on face, neck and arms. Was administered 0.9% NaCl bolus, then 0.9 % NaCl infusion, Diphenhydramine 50 mg/ml inj. and methylprednisolone sod. succ inj. 125 mg.
On February 5, 2023, I woke up with a very mild sore throat and mild congestion. I took a home antigen COVID-19 test. The result was positive. I reached out to my doctor on February 6, 2023. He started me on PAXLOVID. The symptoms subsided in a couple of days, but I isolated for five days.
My last menstrual cycle was 4/14.  It is a regular cycle. My next cycle came just 2 days after I received the Vaccine dose and was a heavier and more painful cycle than normal.
Vaccine given in left arm (DAPTACEL) on 4/11/13. Parent called center on 4/12/13 concerned with "golf ball sized" lump at area of vaccine. Parent advised to ice x 2 days then apply heat to area after 2 days. Spoke with mom on 4/15/13 who states "lump" is better and pt no longer complains of pain.
Nausea, chills, body aches. The weirdest symptom is that both vaccinations (Pfizer, administered on 3/17 and 4/7) caused me to start my period within 24 hours of each shot.
Patient presented on 9/5/2021 to the emergency department with weakness and inability to ambulate. She was previously admitted from 9/2/2021 to 9/3/2021 for lightheadedness, hypotension, chest pain and shortness of breath. She was found to be COVID-19 positive and was admitted for further management. She was treated with dexamethasone, remdesivir, and supplemental oxygen. She was able to be weaned off oxygen prior to discharge. Patient was discharged to home on 9/10/2021.
Menstrual cycle arrived 2 weeks early. I am always outside the 28 window mark. Anywhere from 30-40 days is my regular.  I've never been early. Cramps are usually minimal for me, no need for medication and only one day of real discomfort. Cramps where instant and I needed a pain killers yesterday and today. Today subsided in the evening.
Patient received injection at 933am. Patient called pharmacy at 4pm reporting shaking since vaccine administration. Patient also reported GI distress of stomach ache and diarrhea, along with fever and headache.
Pt described an extended time of vaccination site pain. Pt receive the vaccine in october and still experiencing pain in december. Symptoms include limited ROM with pain at the injection site. no redness or fever. Pt describes pain and numbness from shoulder down to fingertips. Current treatment with NSAIDS and Neurontin. Pt referred to physical therapy.
asymptomatic, tested positive for covid on binax rapid antigen test, test performed as follow up to known exposure
This spontaneous report was received from a Licensed Practical Nurse referring to a patient of unknown gender who would be 17 months old. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX lot # M023384 and expiration date on 20-JUL-2018 of lot # M033906 with expiration date on 06-JUN-2019 (dose and route of administration were not reported) for prophylaxis. The reporter could not provide details of which lot number the patient received. The doses VARIVAX were exposed to a temperature excursion of 14.9 degrees Fahrenheit (°F) during a time frame of 11 hours, which was detected by the data logger. There was no prior temperature excursion and no adverse events were reported. This is one of the several reports received from the same source.; Sender's Comments: US-009507513-1710USA008686: US-009507513-1710USA001141: US-009507513-1710USA008688: US-009507513-1710USA008690: US-009507513-1710USA008691: US-009507513-1710USA008692: US-009507513-1710USA008685: US-009507513-1710USA008684: US-009507513-1710USA008687: US-009507513-1710USA008689:
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On an unknown date, the unspecified number of patients were vaccinated with improperly stored (in temperature 34-35 - unit unknown) unspecified doses of ROTATEQ lot#K016275, expiry date 20-APR-2016 or lot# reported as L004453, expiry date 27-MAY-2016 (dose, site and route of administration were not reported). This is one of several reports received from the same reporter. Additional information has been requested.
pt recv vax & had a violent rxn of n/v/d, etc that lasted approx 1wk;
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient received booster dose. No concomitant medications were reported. The vial was initially stored in the refrigerator on 04-Nov-2021. Dates of administration of vaccine Some were on 05-Nov-2021 and the other doses on 12-Nov-2021.The vial did not undergone any temperature excursions. HCP stated that no adverse event occurred as a result of this misadministration, patients were monitored. No treatment medications were reported.
bump on neck; For 12 hours he experienced Chills; headache; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (For 12 hours he experienced Chills), HEADACHE (headache), PYREXIA (fever) and SWELLING (bump on neck) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced CHILLS (For 12 hours he experienced Chills), HEADACHE (headache) and PYREXIA (fever). On 07-Apr-2021, the patient experienced SWELLING (bump on neck). On 01-Apr-2021, CHILLS (For 12 hours he experienced Chills), HEADACHE (headache) and PYREXIA (fever) had resolved. At the time of the report, SWELLING (bump on neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  His Primary HCP today says not from the shot and wants to give him steroids and antibiotics. He wants to know if these side effects have been reported.
Patient presented to office approximately 24 hrs later with localized redness, swelling, tenderness to site of injection of VARIVAX booster.
Extremely bloated - 2 weeks Fatigue - 3 weeks Skin sensitivity and rash - 2 weeks